Bioray Biotech Co. Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was TWD 62.714 million compared to TWD 86.009 million a year ago. Operating loss was TWD 7.373 million compared to operating Income of TWD 4.800 million a year ago. Net loss was TWD 6.586 million compared to net income of TWD 4.583 million a year ago. Basic loss per share from continuing operations was TWD 0.25 compared to basic earnings per share from continuing operations of TWD 0.17 a year ago.